BEIJING: China is investigating claims of academic fraud involving mostly Chinese cancer researchers after more than 100 articles were withdrawn from a foreign medical journal.
German publisher Springer announced in April the retraction of 107 articles from Tumor Biology after finding evidence the “peer review process was compromised”.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.